The National Times - AI 'arms race' risks human extinction, warns top computing expert

AI 'arms race' risks human extinction, warns top computing expert


AI 'arms race' risks human extinction, warns top computing expert
AI 'arms race' risks human extinction, warns top computing expert / Photo: © AFP

Tech CEOs are locked in an artificial intelligence "arms race" that risks wiping out humanity, top computer science researcher Stuart Russell told AFP on Tuesday, calling for governments to pull the brakes.

Change text size:

Russell, a professor at the University of California, Berkeley, said the heads of the world's biggest AI companies understand the dangers posed by super-intelligent systems that could one day overpower humans.

To him, the onus to save the species rests on world leaders who can take collective action.

"For governments to allow private entities to essentially play Russian roulette with every human being on earth is, in my view, a total dereliction of duty," said Russell, a prominent voice on AI safety.

Countries and companies are spending hundreds of billions of dollars on building energy-hungry data centres to train and run generative AI tools.

The rapidly developing technology promises benefits such as drug discovery, but could also lead to job losses, and facilitate surveillance and online abuse among other threats.

Alongside that is the risk of "AI systems themselves taking control and human civilisation being collatoral damage in that process", Russell said in an interview at the AI Impact Summit in New Delhi.

"Each of the CEOs of the main AI companies, I believe, wants to disarm" but cannot do so "unilaterally" as they would be fired by investors, he said.

"Some of them have said it in public and some of the told me it privately," he added, noting that even Sam Altman, head of ChatGPT maker OpenAI, has said on-record that AI could lead to human extinction.

OpenAI and rival US startup Anthropic have seen public resignations of staff who have spoken out about their ethical concerns.

Anthropic also warned last week that its latest chatbot models could be nudged towards "knowingly supporting -- in small ways -- efforts toward chemical weapon development and other heinous crimes".

- Human 'imitators' -

International gatherings such as this week's AI summit provide an opportunity for regulation, although its three previous editions have only resulted in voluntary agreements from tech companies.

"It really helps if each of the governments understand this issue. And so that's why I'm here," Russell said.

India is hoping the five-day AI summit, attended by tech bosses and dozens of high-level national delegations, will help it power ahead in the sector.

Indian IT minister Ashwini Vaishnaw said Tuesday that the country expects more than $200 billion in AI investments over the next two years, including roughly $90 billion already committed.

Meanwhile fears that AI assistant tools could lead to mass redundancies in India's larges customer service and tech support sectors has caused shares in the country's outsourcing firms to plunge in recent days.

These kind of back-end jobs in India are ripe for replacement with AI, Russell said.

"We are creating human imitators. And so of course, the natural application for that type of system is replacing humans."

Russell is sensing a burgeoning backlash against AI, "particularly among younger people".

"They actually are pushing back against the dehumanising aspects of AI," he said.

"When you're taking over all cognitive functions -- the ability to answer a question, to make a decision, to make a plan... you are turning someone into less than a human being. The young people do not want that."

A.M.James--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: